---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-082155"
form_type: "8-K"
ticker: "RNAZ"
cik: "0001829635"
company_name: "Transcode Therapeutics, Inc."
filed_at: "2024-07-24T23:59:59+00:00"
generated_at: "2026-05-31T17:05:05.220645+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# TransCode Therapeutics prices $3.0M public offering of 10M shares at $0.30

## Summary
- Offering of 10,000,000 common shares at $0.30 per share for gross proceeds of $3.0M.
- Placement agent warrants to purchase 500,000 shares at $0.375, expiring July 22, 2029.
- Expected close on July 24, 2024; proceeds for TTX-MC138 clinical trials and working capital.
- ThinkEquity acting as sole placement agent; securities offered via effective S-3 shelf.

## SEC filing metadata
- accession: 0001104659-24-082155
- form_type: 8-K
- ticker: RNAZ
- cik: 0001829635
- company_name: Transcode Therapeutics, Inc.
- filed_at: 2024-07-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829635/000110465924082155/0001104659-24-082155-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829635/000110465924082155/tm2416389d3_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-082155
- JSON: https://secwatch.observer/filing/0001104659-24-082155.json
- Plain text: https://secwatch.observer/filing/0001104659-24-082155.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.